|
UNK expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.604300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.041560E-02 |
| Normal-vs-Stage2 |
3.360200E-01 |
| Normal-vs-Stage3 |
2.894800E-01 |
| Normal-vs-Stage4 |
9.191600E-01 |
| Stage1-vs-Stage2 |
2.247000E-01 |
| Stage1-vs-Stage3 |
6.163500E-02 |
| Stage1-vs-Stage4 |
9.281500E-03 |
| Stage2-vs-Stage3 |
8.859800E-01 |
| Stage2-vs-Stage4 |
3.711400E-01 |
| Stage3-vs-Stage4 |
3.254800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.357150E-01 |
| Normal-vs-AfricanAmerican |
2.329800E-02 |
| Normal-vs-Asian |
3.797100E-04 |
| Caucasian-vs-AfricanAmerican |
8.102000E-02 |
| Caucasian-vs-Asian |
8.358700E-04 |
| AfricanAmerican-vs-Asian |
2.597700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.993000E-01 |
| Normal-vs-Female |
3.116600E-03 |
| Male-vs-Female |
2.162400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.976000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.685600E-02 |
| Normal-vs-Age(61-80Yrs) |
8.079900E-02 |
| Normal-vs-Age(81-100Yrs) |
5.834200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.068200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.235400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.127800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.955800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.977200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.205000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.8102999999996E-05 |
| Normal-vs-Grade 2 |
8.840700E-03 |
| Normal-vs-Grade 3 |
3.839200E-01 |
| Normal-vs-Grade 4 |
7.530800E-01 |
| Grade 1-vs-Grade 2 |
5.101900E-03 |
| Grade 1-vs-Grade 3 |
3.76280000000673E-05 |
| Grade 1-vs-Grade 4 |
8.6162000001444E-07 |
| Grade 2-vs-Grade 3 |
6.837700E-03 |
| Grade 2-vs-Grade 4 |
4.825000E-04 |
| Grade 3-vs-Grade 4 |
1.834970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.103700E-03 |
| Normal-vs-ccB subtype |
2.078800E-01 |
| ccA subtype-vs-ccB subtype |
1.168020E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.404200E-02 |
| Normal-vs-N1 |
6.776400E-01 |
| N0-vs-N1 |
5.566400E-01 |
|
|
